Colgate-Palmolive Company: Q3 2001 10-Q Summary
Business Context and Reporting Period
This Quarterly Report on Form 10-Q covers the period ended September 30, 2001. Colgate-Palmolive Company operates globally in Oral, Personal, and Household Care, as well as Pet Nutrition. The company reported 551.7 million shares of common stock outstanding as of October 31, 2001.
Key Financial Metrics
| Metric (in Millions) | Q3 2001 | Q3 2000 | 9M 2001 | 9M 2000 |
|---|---|---|---|---|
| Net Sales | $2,391.2 | $2,366.5 | $7,013.4 | $6,945.0 |
| Gross Profit | $1,319.2 | $1,293.5 | $3,857.6 | $3,785.6 |
| Gross Margin | 55.2% | 54.7% | 55.0% | 54.5% |
| Net Income | $296.2 | $275.3 | $851.3 | $777.1 |
| Diluted EPS | $0.49 | $0.44 | $1.40 | $1.24 |
| Operating Cash Flow (9M) | $1,097.8 (vs $1,081.8 prior year) | |||
| Cash & Equivalents | $289.6 (as of Sept 30, 2001) | |||
| Total Debt | $3,546.2 (Current $462.9 + Long-term $3,083.3) |
Material Changes vs. Prior Period
- Sales Growth: Q3 sales increased 2.0% year-over-year. Excluding divestments and foreign currency impacts, sales rose 5.0% driven by unit volume gains of 5.5%.
- Profitability: Net income rose 8% in Q3 and 10% for the nine-month period. Earnings Before Interest and Taxes (EBIT) margin improved to 19.9% in Q3 from 18.7% in the prior year.
- Cost Efficiency: Selling, general, and administrative (SG&A) expenses as a percentage of sales decreased to 35.3% in Q3 from 36.0% in 2000, aided by efficiencies and currency translation effects.
- Debt Levels: Total debt increased compared to the prior year end, though interest expense decreased due to lower interest rates.
- Share Repurchases: The company spent $1,059.2 million on common stock purchases during the first nine months of 2001, compared to $704.0 million in the prior year.
Outlook, Risks, and Unusual Items
- Foreign Currency Impact: Significant headwinds from foreign currency declines offset volume growth in all regions. A specific charge to cumulative translation adjustment was recorded due to the devaluation of the Brazilian real, impacting comprehensive income.
- Accounting Changes: The company will adopt SFAS No. 141 and 142 effective January 1, 2002. This will cease the amortization of goodwill and indefinite-life intangible assets, expected to increase future net income. Management preliminarily assesses that any impairment charge upon adoption will not be material.
- Product Performance: Growth was driven by Oral Care (Colgate Total, Actibrush) and Personal Care (Softsoap, Palmolive). Pet Nutrition (Hill's) saw a 9.0% sales increase in Q3.
- Liquidity: Operating cash flow increased 1% year-over-year. A non-recurring tax payment related to the sale of the Viva detergent brand in Mexico impacted the prior year's cash flow comparison.
Investor Verification Checklist
- Verify the impact of the Brazilian real devaluation on future asset valuations and amortization schedules.
- Monitor the quantification of the net income increase expected from the adoption of SFAS 142 (Goodwill) in 2002.
- Assess the sustainability of volume growth (5.5%) given the persistent negative impact of foreign exchange rates.
- Review the ratio of earnings to fixed charges (Exhibit 12) to evaluate debt service coverage given increased debt levels.
- Confirm the timeline and financial impact of the "360-degree advertising" shift to sales reductions.